๐ŸŽ Black Friday: up to 50% off of annual plans
AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX ยท Real-Time Price ยท USD
5.08
-0.14 (-2.68%)
At close: Nov 20, 2026, 4:00 PM EST
5.10
+0.02 (0.39%)
After-hours: Nov 20, 2026, 7:30 PM EST

AN2 Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-37.44-38.11-54.55-69.64-42.26-21.57
Net Income
-34.88-35.17-51.32-64.73-42.78-28.06
Earnings Per Share
-0.90-1.16-1.72-2.74-2.79-10.64
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
64.45883.62107.396.0658.56
Total Debt
----0.05-
Net Cash (Debt)
64.45883.62107.396.0158.56
Net Cash Growth
4.00%-30.64%-22.07%11.76%63.96%1338.70%
Net Cash Per Share
1.661.922.804.556.2622.20

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-30.41-29.83-49.26-53.29-33.46-20.48
Free Cash Flow
-30.41-29.83-49.26-53.29-33.46-20.48
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.